These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23382223)

  • 1. Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.
    Gostissa M; Bianco JM; Malkin DJ; Kutok JL; Rodig SJ; Morse HC; Bassing CH; Alt FW
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2934-9. PubMed ID: 23382223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
    Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
    Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.
    DeMicco A; Yang-Iott K; Bassing CH
    Cell Cycle; 2013 Oct; 12(20):3307-16. PubMed ID: 24036547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
    Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
    J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching.
    Wang JH; Alt FW; Gostissa M; Datta A; Murphy M; Alimzhanov MB; Coakley KM; Rajewsky K; Manis JP; Yan CT
    J Exp Med; 2008 Dec; 205(13):3079-90. PubMed ID: 19064702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas.
    Chiang YJ; Difilippantonio MJ; Tessarollo L; Morse HC; Hodes RJ
    PLoS One; 2012; 7(11):e49305. PubMed ID: 23166633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
    Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
    J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
    Bassing CH; Suh H; Ferguson DO; Chua KF; Manis J; Eckersdorff M; Gleason M; Bronson R; Lee C; Alt FW
    Cell; 2003 Aug; 114(3):359-70. PubMed ID: 12914700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
    Yin B; Yang-Iott KS; Chao LH; Bassing CH
    Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice.
    Yamamoto K; Lee BJ; Li C; Dubois RL; Hobeika E; Bhagat G; Zha S
    Leukemia; 2015 Jun; 29(6):1414-24. PubMed ID: 25676421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer.
    Adams CM; Eischen CM
    Cancer Res; 2014 Jul; 74(14):3923-34. PubMed ID: 24840646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
    Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
    Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
    Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
    Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.
    Walsh SH; Rosenquist R
    Med Oncol; 2005; 22(4):327-41. PubMed ID: 16260850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.
    Robbiani DF; Bunting S; Feldhahn N; Bothmer A; Camps J; Deroubaix S; McBride KM; Klein IA; Stone G; Eisenreich TR; Ried T; Nussenzweig A; Nussenzweig MC
    Mol Cell; 2009 Nov; 36(4):631-41. PubMed ID: 19941823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.
    Yang X; Lee K; Said J; Gong X; Zhang K
    Blood; 2006 Sep; 108(6):2006-12. PubMed ID: 16728698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
    Seifert M; Küppers R
    Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.
    Weniger MA; Seifert M; Küppers R
    Methods Mol Biol; 2025; 2865():1-30. PubMed ID: 39424718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytometric detection of DNA amplified with fluorescent primers: applications to analysis of clonal bcl-2 and IgH gene rearrangements in malignant lymphomas.
    Barker RL; Worth CA; Peiper SC
    Blood; 1994 Feb; 83(4):1079-85. PubMed ID: 8111048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.